These medications jump in and activate many times more GLP-1 than your body can produce
The studies included analyzes of clinical records and real-world databases tracking patients taking Novo Nordisks NOVOb.CO Wegovy or Ozempic, Eli Lillys LLY.N Zepbound or Mounjaro, or older GLP-1 treatments
If youre struggling with a plateau, consider consulting with a concierge physician to develop a customized weight management plan that incorporates advanced metabolic therapies
We offer personalized IV plans to address your health concerns
Combining two ingredients that both have GI side effect potential could theoretically worsen tolerability, particularly during the early dose titration phase when the body is still adjusting to tirzepatide
In the SUSTAIN FORTE clinical trials, participants in the semaglutide (Ozempic) group showed an average reduction of 2.2 percentage points in the HbA1c levels with a 2 mg weekly dosage and 1.9 percentage points with a 1 mg weekly dosage of semaglutide after 40 weeks